Concord Medical

company

About

Concord Medical Services Holdings Limited (Concord Medical) operates a network of radiotherapy and diagnostic imaging centers in China.

  • 501 - 1000

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
¥700M
Industries
Health Care,Health Diagnostics,Medical
Founded date
Jan 1, 2007
Number Of Employee
501 - 1000
Operating Status
Active

Concord Medical Services Holdings Limited (Concord Medical) operates a network of radiotherapy and diagnostic imaging centers in China. As of December 31, 2012,its network comprised 136 centers based in 76 hospitals, spanning 53 cities across 24 provinces and administrative regions in China. These hospitals are substantially comprised of 3A hospitals, the highest ranked hospitals by quality and size in China as determined in accordance with the standards of the Ministry of Health. In June 2012, the Company acquired through Cyber Medical and Shanghai Medstar 52% of the equity interest in Chang’an Hospital. In December 2012, the Company acquired 19.98% of equity interest in The University of Texas MD Anderson Cancer Center Proton Therapy Center, a proton treatment center in the world.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥700M
Concord Medical has raised a total of ¥700M in funding over 2 rounds. Their latest funding was raised on Mar 11, 2020 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 11, 2020 Post-IPO Equity ¥700M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Concord Medical is funded by 1 investors. CITIC Industrial Investment Group are the most recent investors.
Investor Name Lead Investor Funding Round
CITIC Industrial Investment Group Post-IPO Equity